Skip to main content

AtriCure Inc

For the period ended Dec 31, 2023. Filed Feb 16, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 16, 2024

ATRC$56.26-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Operations and Comprehensive (Loss) Income

YEARS ENDED DECEMBER 31, 2023, 2022 and 2021

202320222021
Revenue$399,245$330,379$274,329
Cost of revenue98,87584,43968,469
Gross profit300,370245,940205,860
Operating expenses (benefit):
Research and development expenses73,91557,33748,506
Selling, general and administrative expenses253,138231,272204,649
Change in fair value of contingent consideration (Note 2)——(184,800)
Intangible asset impairment (Note 4)——82,300
Total operating expenses327,053288,609150,655
(Loss) income from operations(26,683)(42,669)55,205
Other income (expense):
Interest expense(6,925)(4,986)(4,918)
Interest income3,7921,994466
Other(31)(537)(366)
(Loss) income before income tax expense(29,847)(46,198)50,387
Income tax expense591268188
Net (loss) income$(30,438)$(46,466)$50,199
Net (loss) income per share:
Basic net (loss) income per share$(0.66)$(1.02)$1.11
Diluted net (loss) income per share$(0.66)$(1.02)$1.09
Weighted average shares outstanding:
Basic46,30945,74045,066
Diluted46,30945,74046,039
Comprehensive (loss) income:
Unrealized gain (loss) on investments$2,898$(2,811)$(941)
Foreign currency translation adjustment205(337)(319)
Other comprehensive income (loss)3,103(3,148)(1,260)
Net (loss) income(30,438)(46,466)50,199
Comprehensive (loss) income, net of tax$(27,335)$(49,614)$48,939
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.